RATIONALE: Oral immunotherapy (OIT) desensitization is an emerging treatment for food allergy. Despite attempts to minimize adverse events during desensitization, many participants still experience gastrointestinal symptoms and some develop eosinophilic esophagitis (EoE). It is unclear whether these subjects have subclinical esophageal eosinophilia (EE) at baseline. We evaluated the presence of EE in subjects with food allergy before peanut OIT. METHODS: Baseline esophagogastroduodenoscopies (EGD) were conducted with 21 adults before peanut OIT. Endoscopic findings were assessed using the EoE Endoscopic Reference Score (EREFS), and biopsies were obtained from the proximal, middle, and distal esophagus. Esophageal biopsies were evaluated using the EoE Histologic Scoring System (EoEHSS). Hematoxylin and eosin stains of each biopsy were assessed for eosinophil density. Automated image analysis of eosinophil peroxidase (EPX) immunohistochemistry was also performed to assess eosinophil degranulation. RESULTS: All subjects were asymptomatic at enrollment. Pre-existing EE was present in 5 participants (24%), 3 (14%) of whom had >15 eosinophils per high-power field (eos/hpf) associated with mild endoscopic findings (edema, linear furrowing, or rings; median EREFS50, IQR 0-0.25). Some subjects also demonstrated basal cell hyperplasia, dilated intercellular spaces, and lamina propria fibrosis of the esophageal mucosa. EPX deposition (EPX/mm 2 ) correlated with eos/hpf (r50.53, p<0.0001) CONCLUSIONS: EE is present in some (24% in this study) adults with IgE-mediated peanut allergy before initiation of OIT. Such eosinophilic inflammation may be accompanied by mild endoscopic and histologic findings. Additional EGD and biopsies for longitudinal data collection during OIT are ongoing and may provide insight into mechanisms underlying gastrointestinal side effects. Phoenix Children's Hospital Department of Allergy and Immunology, Phoenix, AZ. RATIONALE: Diagnosis and treatment of eosinophilic esophagitis (EoE) requires multiple endoscopic biopsies. The Cytosponge is a minimally invasive method to sample the esophageal epithelium. As tissue eosinophils undergo degranulation in EoE, we hypothesized that eosinophil peroxidase (EPX) deposition would correlate with eosinophils per high power field (eos/hpf) and enhance the diagnostic accuracy of the Cytosponge. METHODS: Matched biopsies and Cytosponge specimens obtained in a previously conducted prospective study (n572 from 60 patients) were stained for hematoxylin and eosin (H&E) and EPX; 43 were graded as active EoE (> _15 eos/hpf). EPX stains were digitized and analyzed for EPXpositive pixels (area50.307 mm 2 ). EPX/mm 2 (biopsy and Cytosponge) was compared to H&E eos/hpf (biopsy) to assess correlations (Spearman's rho) and ROC curves were generated. RESULTS: EPX/mm 2 from both the biopsy and Cytosponge specimens correlated strongly with eos/hpf (H&E esophageal biopsy) [r50.75, (0.62, 0.83 95% CI), p<0.0001 and r50.72, (0.59, 0.82 
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